Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Duchenne muscular dystrophy gene carrier+1

Recruiting

InvestigationalNo placebo

Long‑Term Safety and Efficacy Study of ENTR‑601‑45 and ENTR‑601‑44 in Participants with Duchenne Muscular Dystrophy

InvestigationalNo placebo

Belgium

Participants:0–17 years · 18–64 years

Contact Research Centre

Duchenne muscular dystrophy gene carrier+1

Recruiting

Registered drug

Study of ENTR-601-45 Safety and Effectiveness in Patients with Duchenne Muscular Dystrophy Who Can Skip Exon 45

Registered drug

Belgium

Participants:0–17 years · 18–64 years
Substances:Sodium Chloride

Contact Research Centre

Duchenne muscular dystrophy gene carrier+1

Recruiting

Registered drug

Study of ENTR-601-44 in Children with Duchenne Muscular Dystrophy Who Are Eligible for Exon 44 Skipping Treatment

Registered drug

Belgium

Participants:0–17 years · 18–64 years
Substances:Sodium Chloride

Contact Research Centre

Duchenne muscular dystrophy gene carrier+1

Recruiting

InvestigationalNo placebo

Long-term Safety Study of Delandistrogene Moxeparvovec for Patients with Duchenne Muscular Dystrophy Who Previously Received SRP-9001

InvestigationalNo placebo

Belgium

Participants:0–17 years · 18–64 years
Substances:Delandistrogene Moxeparvovec

Contact Research Centre

Duchenne muscular dystrophy gene carrier+1

Not yet recruiting

Investigational

Study on the Safety and Effectiveness of Delandistrogene Moxeparvovec for Patients with Duchenne Muscular Dystrophy

Investigational

Belgium

Participants:0–17 years · 18–64 years
Substances:Delandistrogene Moxeparvovec

Contact Research Centre

Duchenne muscular dystrophy gene carrier+1

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effects of Delandistrogene Moxeparvovec in Children Under 4 with Duchenne Muscular Dystrophy

InvestigationalNo placebo

Belgium

Participants:0–17 years
Substances:Delandistrogene Moxeparvovec

Contact Research Centre

Duchenne muscular dystrophy gene carrier

Not recruiting

Registered drugNo placebo

Study on the Safety and Efficacy of Delandistrogene Moxeparvovec and Imlifidase for Patients with Duchenne Muscular Dystrophy with Pre-existing Antibodies

Registered drugNo placebo

Spain

Participants:0–17 years
Substances:Imlifidase

Contact Research Centre

Duchenne muscular dystrophy gene carrier

Not recruiting

InvestigationalNo placebo

Study to Determine the Best Dose of Vesleteplirsen for Patients with Duchenne Muscular Dystrophy Suitable for Exon 51-Skipping Treatment

InvestigationalNo placebo

Belgium

Participants:0–17 years · 18–64 years
Substances:Vesleteplirsen

Contact Research Centre

Find therapies in clinical trials near you

8 trials match your criteria

Duchenne muscular dystrophy gene carrier+1

Long‑Term Safety and Efficacy Study of ENTR‑601‑45 and ENTR‑601‑44 in Participants with Duchenne Muscular Dystrophy

Duchenne muscular dystrophy gene carrier+1

Study of ENTR-601-45 Safety and Effectiveness in Patients with Duchenne Muscular Dystrophy Who Can Skip Exon 45

Duchenne muscular dystrophy gene carrier+1

Study of ENTR-601-44 in Children with Duchenne Muscular Dystrophy Who Are Eligible for Exon 44 Skipping Treatment

Duchenne muscular dystrophy gene carrier+1

Long-term Safety Study of Delandistrogene Moxeparvovec for Patients with Duchenne Muscular Dystrophy Who Previously Received SRP-9001

Duchenne muscular dystrophy gene carrier+1

Study on the Safety and Effectiveness of Delandistrogene Moxeparvovec for Patients with Duchenne Muscular Dystrophy

Duchenne muscular dystrophy gene carrier+1

Study on the Safety and Effects of Delandistrogene Moxeparvovec in Children Under 4 with Duchenne Muscular Dystrophy

Duchenne muscular dystrophy gene carrier

Study on the Safety and Efficacy of Delandistrogene Moxeparvovec and Imlifidase for Patients with Duchenne Muscular Dystrophy with Pre-existing Antibodies

Duchenne muscular dystrophy gene carrier

Study to Determine the Best Dose of Vesleteplirsen for Patients with Duchenne Muscular Dystrophy Suitable for Exon 51-Skipping Treatment

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.